Does ANASTROZOLE Cause Second primary malignancy? 88 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 88 reports of Second primary malignancy have been filed in association with ANASTROZOLE (Anastrozole). This represents 0.8% of all adverse event reports for ANASTROZOLE.
88
Reports of Second primary malignancy with ANASTROZOLE
0.8%
of all ANASTROZOLE reports
21
Deaths
29
Hospitalizations
How Dangerous Is Second primary malignancy From ANASTROZOLE?
Of the 88 reports, 21 (23.9%) resulted in death, 29 (33.0%) required hospitalization, and 22 (25.0%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ANASTROZOLE. However, 88 reports have been filed with the FAERS database.
What Other Side Effects Does ANASTROZOLE Cause?
Arthralgia (1,409)
Fatigue (1,215)
Nausea (1,049)
Malignant neoplasm progression (1,006)
Diarrhoea (851)
Metastases to bone (758)
Headache (725)
Dyspnoea (678)
Asthenia (649)
Dizziness (596)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which ANASTROZOLE Alternatives Have Lower Second primary malignancy Risk?
ANASTROZOLE vs ANDEXANET ALFA
ANASTROZOLE vs ANDROGEL
ANASTROZOLE vs ANETHOLTRITHION
ANASTROZOLE vs ANGIOTENSIN II
ANASTROZOLE vs ANHYDROUS CITRIC ACID\ASPIRIN\SODIUM BICARBONATE